| |
| |
|
| Insider
Information: |
Patou Gary |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
37,714 |
|
|
Indirect Shares
|
5,604 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$19,747 |
|
|
| Total
Shares |
43,318 |
|
|
| Total
Value |
$19,747 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
14,141 |
2004-11-02 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Chief Medical Officer |
2014-08-07 |
0 |
2014-08-07 |
702 |
Premium* |
|
|
Xenon Pharmaceuticals Inc. |
XENE |
|
2023-12-13 |
23,573 |
2023-12-14 |
4,902 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
150 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-25 |
4 |
AS |
$2.15 |
$9,675 |
D/D |
(4,500) |
377,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-28 |
4 |
AS |
$3.53 |
$17,650 |
D/D |
(5,000) |
54,347 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-30 |
4 |
AS |
$2.25 |
$11,250 |
D/D |
(5,000) |
355,238 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-20 |
4 |
AS |
$2.11 |
$10,550 |
D/D |
(5,000) |
367,855 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-07-14 |
4 |
AS |
$2.60 |
$13,000 |
D/D |
(5,000) |
375,078 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-26 |
4 |
AS |
$2.05 |
$10,250 |
D/D |
(5,000) |
382,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-26 |
4 |
AS |
$2.09 |
$10,450 |
D/D |
(5,000) |
377,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-29 |
4 |
AS |
$2.15 |
$10,750 |
D/D |
(5,000) |
377,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-29 |
4 |
OE |
$0.07 |
$350 |
D/D |
5,000 |
382,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-09-30 |
4 |
OE |
$0.07 |
$350 |
D/D |
5,000 |
397,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-09-30 |
4 |
AS |
$2.20 |
$11,000 |
D/D |
(5,000) |
392,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-11-18 |
4 |
OE |
$0.07 |
$350 |
D/D |
5,000 |
397,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-11-18 |
4 |
AS |
$2.08 |
$10,418 |
D/D |
(5,000) |
392,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-11-28 |
4 |
AS |
$2.00 |
$10,000 |
D/D |
(5,000) |
392,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-11-28 |
4 |
OE |
$0.07 |
$350 |
D/D |
5,000 |
397,856 |
|
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-08-08 |
4 |
B |
$3.00 |
$15,003 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-15 |
4 |
OE |
$0.07 |
$385 |
D/D |
5,500 |
383,356 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-15 |
4 |
AS |
$2.80 |
$15,400 |
D/D |
(5,500) |
377,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-30 |
4 |
OE |
$0.07 |
$389 |
D/D |
5,556 |
360,238 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-20 |
4 |
OE |
$1.18 |
$6,556 |
D/D |
5,556 |
372,855 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-07-14 |
4 |
OE |
$0.07 |
$389 |
D/D |
5,556 |
380,078 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-28 |
4 |
OE |
$0.07 |
$448 |
D/D |
6,407 |
48,347 |
|
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-08-10 |
4 |
B |
$2.78 |
$20,836 |
I/I |
7,500 |
12,500 |
2.1 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-13 |
4 |
S |
$41.05 |
$311,898 |
I/I |
(7,598) |
4,902 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-14 |
4/A |
S |
$41.05 |
$311,898 |
I/I |
(7,598) |
4,902 |
0 |
- |
|
150 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
